SLINTEC and Multilac Care launch NOVID Antiviral Spray
In a pioneering initiative to battle against COVID-19, Multilac Care together with the Sri Lanka Institute of Nanotechnology (SLINTEC) recently launched Sri Lanka’s first ever Antiviral and Antibacterial Spray. The new NOVID antiviral and antibacterial spray is the first of its kind to be launched in Sri Lanka and it is proven to kill 99% of coronavirus.
A major highlight to this spray is that a single application can last a longer period ensuring a high level of protection when compared to traditional disinfectants which are only effective for a shorter period.
SLINTEC Chief of Research and Innovation Dr. Azeez M Mubarak said, “Innovation has always been a key factor in economic growth of successful nations. But to translate research results to economic returns, active collaboration between R&D institutes and industry is a must. And NOVID, the result of a fruitful partnership between SLINTEC and Multilac care is a prime example in this regard.”
Sharing thoughts on the NOVID antiviral and antibacterial spray, Director/ CEO of Multilac Care, Mizha Mizver said, “We are extremely proud to be on the cutting edge, and to play our role in the fight against coronavirus.”
Read more: DailyFT | Sunday Observer
